Differences in biomarker testing in non-small cell lung cancer: real-world outcomes within an integrated healthcare system

IntroductionWhile biomarker testing can guide lung cancer treatment, its real-world application in community practice remains underexplored. This study examines the prevalence, predictors, and outcomes of biomarker testing in non-small cell lung cancer (NSCLC).MethodsThis retrospective cohort study...

全面介紹

書目詳細資料

Principais autores:	William P. Carroway, Nathan J. Alcasid, Alberto Jarrin Lopez, Kenneth Williams, Varada Sarovar, Huyun Dong, Wendy Dyer, Jingrong Yang, Lori C. Sakoda, Jeffrey B. Velotta
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2025-11-01
叢編:	Frontiers in Surgery
主題:	non-small cell lung cancer (NSCLC) biomarker testing next-generation sequencing(NGS) survival outcomes health disparities
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fsurg.2025.1632360/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!